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Abstract
Introduction Despite the key role of hemodynamic goals, there
are few data addressing the question as to which hemodynamic
variables are associated with outcome or should be targeted in
cardiogenic shock patients. The aim of this study was to
investigate the association between hemodynamic variables and
cardiogenic shock mortality.
Methods Medical records and the patient data management
system of a multidisciplinary intensive care unit (ICU) were
reviewed for patients admitted because of cardiogenic shock. In
all patients, the hourly variable time integral of hemodynamic
variables during the first 24 hours after ICU admission was
calculated. If hemodynamic variables were associated with 28-
day mortality, the hourly variable time integral of drops below
clinically relevant threshold levels was computed. Regression
models and receiver operator characteristic analyses were
calculated. All statistical models were adjusted for age,
admission year, mean catecholamine doses and the Simplified
Acute Physiology Score II (excluding hemodynamic counts) in
order to account for the influence of age, changes in therapies
during the observation period, the severity of cardiovascular
failure and the severity of the underlying disease on 28-day
mortality.
Results One-hundred and nineteen patients were included.
Cardiac index (CI) (P = 0.01) and cardiac power index (CPI) (P
= 0.03) were the only hemodynamic variables separately
associated with mortality. The hourly time integral of CI drops
<3, 2.75 (both P = 0.02) and 2.5 (P = 0.03) L/min/m2 was
associated with death but not that of CI drops <2 L/min/m2 or
lower thresholds (all P > 0.05). The hourly time integral of CPI
drops <0.5-0.8 W/m2 (all P = 0.04) was associated with 28-day
mortality but not that of CPI drops <0.4 W/m2  or lower
thresholds (all P > 0.05).
Conclusions During the first 24 hours after intensive care unit
admission, CI and CPI are the most important hemodynamic
variables separately associated with 28-day mortality in patients
with cardiogenic shock. A CI of 3 L/min/m2 and a CPI of 0.8 W/
m2 were most predictive of 28-day mortality. Since our results
must be considered hypothesis-generating, randomized
controlled trials are required to evaluate whether targeting these
levels as early resuscitation endpoints can improve mortality in
cardiogenic shock.
Introduction
Catecholamine inotropes are the traditional pharmacologic
agents used to stabilize hemodynamic function in cardiogenic
shock patients [1,2]. Although catecholamines can increase
systemic blood flow and ensure tissue perfusion [3], there are
few beneficial effects on the heart itself. In contrast, numerous
adverse effects of adrenergic agents on heart function have
been reported [1,4]. These range from tachycardia/tachyar-
rhythmia [5] and myocardial stunning [6-8] to necrosis and
apoptosis [9]. Adverse cardiac effects of catecholamines are
frequently dose-dependent and may counteract re-establish-
ment of normal heart function [1,4,7-10].
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Aside from the severity of the underlying cardiac pathology,
the extent of catecholamine support in cardiogenic shock
patients is largely determined by the level of the prescribed
hemodynamic goals. These should be set to secure tissue per-
fusion while minimizing adrenergic stress on the heart [1,11].
Despite the key role of hemodynamic goals, there are few data
addressing the question of whether hemodynamic variables
are associated with patient outcome or should be used as
treatment goals in cardiogenic shock. Even less evidence
exists about which endpoints of hemodynamic variables
should be increased to optimize outcome. The definition of
hemodynamic variables and their optimum levels for patient
outcome could further help prioritize hemodynamic resuscita-
tion, guarantee tissue perfusion and keep adrenergic stress on
the healing heart as low as possible.
In this explorative, retrospective analysis, the association
between hemodynamic variables and 28-day mortality as well
as hemodynamic variables and indices of tissue perfusion was
evaluated in 119 patients with cardiogenic shock. Additionally,
we sought to identify levels of relevant hemodynamic variables
to predict death at day 28. We hypothesized that one or more
hemodynamic variables were associated with 28-day mortality
and that certain threshold levels of these hemodynamic varia-
bles could best predict 28-day mortality.
Materials and methods
This retrospective, explorative cohort study was performed in
the 30-bed multi-disciplinary intensive care unit of the Inselspi-
tal University Hospital of Bern. Medical records from 1 March,
2005, to 30 June, 2008, were reviewed for patients admitted
to the intensive care unit because of cardiogenic shock. Car-
diogenic shock was defined as the simultaneous presence of
all of the following criteria immediately before or during the first
24 hours after intensive care unit admission: 1) arterial hypo-
tension (systolic arterial blood pressure below 90 mmHg or
mean arterial blood pressure below 70 mmHg for 30 minutes
or longer with or without therapy); 2) a cardiac index below 2
L/min/m2 and a pulmonary artery occlusion pressure above 18
mmHg in patients with a pulmonary artery catheter or an acute
decrease of the left ventricular ejection fraction below 40% in
patients without a pulmonary artery catheter; 3) need for a
continuous infusion of inotropic drugs (any dose of dob-
utamine, epinephrine, milrinone and/or levosimendan).
Patients below the age of 18 years, patients who developed
mechanical complications requiring early cardiac surgery,
patients who developed cardiogenic shock after cardiac sur-
gery, patients who required a mechanical assist device other
than an intra-aortic balloon pump before or during the first 24
hours after intensive care unit admission (n = 5) and patients
who developed cardiogenic shock later during the intensive
care unit stay were excluded from the analysis. Presence of
inclusion and absence of exclusion criteria was verified by
reviewing medical charts and the patient data management
system of all patients admitted to the intensive care unit with
cardiogenic shock. The study protocol was approved by the
Ethic Committee of the Canton of Bern, and the need for an
informed consent was waived.
All study variables were extracted from the medical records
and the institutional patient data management system data-
base (Centricity Critical Care Clinisoft®; General Electrics,
Helsinki, Finland). Routine data recording included demo-
graphic and clinical patient characteristics. Hemodynamic
parameters were prospectively recorded. The system uses
median filtering, which is an effective non-linear, digital filtering
process to eliminate artefacts from a signal. Thus, single
hemodynamic values over two minutes are summarized as a
median value [12]. All laboratory results are automatically
imported into the system. Drugs and fluids administered are
manually entered into the database at the bedside.
Hemodynamic therapy
Arterial, central venous and pulmonary artery catheters (Swan
Ganz CCOmbo® CCO/SvO2/VIP; Edwards Lifesciences Inc.,
Irvine, CA, USA) with continuous cardiac output and mixed
venous oxygen saturation measurement (Vigilance®; Edwards
Lifesciences Inc., Irvine, CA, USA) were in place in 119
(100%), 113 (95%), and 92 (77%) study patients, respec-
tively. Arterial blood pressure measurements were preferably
taken from a radial arterial line and in some patients from a fem-
oral arterial line but never from the descending aorta through
an intra-aortic balloon pump. The hemodynamic management
of study patients was based on an institutional protocol, which
served as a treatment guideline [13]. To maintain individual
cardiac index and mixed venous oxygen saturation between
1.5 and 2.7 L/min/m2  and 55 and 65%, respectively, all
patients were treated with an inotropic agent. Dobutamine and
epinephrine were used as first-line agents, while milrinone
served as a second-line drug. During the first 24 hours after
intensive care unit admission, levosimendan (no bolus injec-
tion, 0.1 to 0.2 μg/kg/min for 24 hours) was administered in
four (3.4%) study patients as a last-resort therapy only. Fluid
resuscitation was guided by the response of arterial blood
pressure, heart rate, central venous pressure, cardiac index,
mixed venous oxygen saturation, and peripheral capillary per-
fusion following repetitive fluid boluses. To optimize left ven-
tricular afterload and coronary perfusion, mean arterial blood
pressure was individually maintained between 50 and 75
mmHg using sodium nitroprusside to decrease or norepine-
phrine to increase systemic vascular resistance, as clinically
indicated. If required mechanical ventilation and/or an intra-
aortic balloon pump (particularly in patients with acute coro-
nary syndrome) were used to further reduce left ventricular
afterload. Packed red blood cells were transfused to increase
mixed venous oxygen saturation when hemoglobin was <70 to
80 g/L.
If possible, the underlying cause of cardiogenic shock was
eliminated. Patients with acute coronary syndromes were re-Available online http://ccforum.com/content/13/5/R157
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vascularized whenever possible using percutaneous coronary
interventions. Measures were taken to keep the door-to-bal-
loon time as short as possible and to perform coronary inter-
ventions before intensive care unit admission. Although stent
implantation was prioritized, the decision to stent coronary
lesions and the type of stent implanted was determined at the
discretion of the operator. Before and after the procedure,
patients without contraindications received a dual anti-platelet
therapy (aspirin and clopidogrel) and heparin combined with
abciximab in case of stent implantation.
Demographic and clinical variables
Demographic data, premorbidities, admission year, cause of
cardiogenic shock and the need for mechanical ventilation, a
ventricular assist device other than an intra-aortic balloon
pump (initiated >24 hours after intensive care unit admission)
or renal replacement therapy during the intensive care unit stay
were documented. The Simplified Acute Physiology Score
(SAPS) II [14] and Sequential Organ Failure Assessment
(SOFA) score [15] were calculated from worst clinical param-
eters during the first 24 hours after intensive care unit admis-
sion (SAPS II) and throughout the intensive care unit stay
(SOFA), respectively. Length of intensive care unit and hospi-
tal stay, as well as patient outcome at intensive care unit dis-
charge was recorded. Twenty eight day-mortality after
intensive care unit admission was retrieved from institutional
records, the hospital database, or in case of transfer to exter-
nal institutions before day 28 by contacting these hospitals.
Hemodynamic variables and indices of tissue perfusion
Hemodynamic variables and indices of tissue perfusion col-
lected during the first 24 hours after intensive care unit admis-
sion were extracted from the institutional patient data
management system database. Manual quality and plausibility
control of individual datasets was performed to exclude arte-
facts (e.g. due to blood sampling via the arterial line). We have
previously demonstrated that clinicians can efficiently detect
artefacts in monitored trends [16]. Mean perfusion pressure
(mean arterial blood pressure-central venous blood pressure)
and - in patients with a pulmonary artery catheter - cardiac
power index (mean arterial blood pressure × cardiac index/
451) [17], coronary perfusion pressure (diastolic arterial blood
pressure-pulmonary artery occlusion pressure) and systemic
vascular resistance index (mean arterial blood pressure-cen-
tral venous blood pressure/cardiac index × 80) were
calculated.
Before entering the hemodynamic variables into the statistical
analysis, the variable time integral during the first 24 hours was
calculated for all parameters (Figure 1). Because of differ-
ences in the actual recorded time of each hemodynamic vari-
able due to diagnostic and/or interventional procedures, the
integral was normalized for the time recorded (hourly integral).
In case of death during the 24 hours of observation time,
hemodynamic variables during the last 30 minutes before car-
diac arrest and variables recorded after the decision to with-
draw life-sustaining therapy were excluded. If hemodynamic
variables revealed a significant association with 28-day mortal-
ity, the hourly variable time integral of drops below clinically rel-
evant threshold levels was calculated (Figure 1). The type and
mean dose of cardiovascular drugs infused during the first 24
hours after intensive care unit admission were also docu-
mented. The most aberrant arterial lactate and base deficit lev-
Figure 1
Schematic description of the cardiac index time integral and the time integral of cardiac index drops below 3 L/min/m2 during the first 24 hours after  intensive care unit admission Schematic description of the cardiac index time integral and the time integral of cardiac index drops below 3 L/min/m2 during the first 24 hours after 
intensive care unit admission.  Dotted area = cardiac index time integral. Coloured area = time integral of cardiac index drops below 3 L/min/m2.Critical Care    Vol 13 No 5    Torgersen et al.
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els were extracted and considered as indices of tissue
perfusion.
Study endpoints
The primary endpoint was to evaluate the association between
hemodynamic variables during the first 24 hours after intensive
care unit admission and 28-day mortality in cardiogenic shock.
Secondary endpoints were to identify cut-off levels of those
hemodynamic variables significantly associated with 28-day
mortality to predict death at day 28, and to evaluate the asso-
ciation between hemodynamic variables and arterial lactate
levels as well as base deficit as indices of tissue perfusion.
Statistical analysis
Statistical analyses were performed using the SPSS 12.0.1.
(SPSS, Chicago, IL, USA) and STATA 9.2. (StataCorp, Col-
lege Station, Tx, USA) software programs. Kolmogorov Smir-
nov tests were applied to check for normality distribution of
variables. In case of non-normal distribution, logarithmic trans-
formation was performed. As appropriate, unpaired student's t
and chi-squared tests were used to compare data between
survivors and non-survivors.
Multivariate binary logistic regression models were calculated
to evaluate the association between the hourly variable time
integral of different hemodynamic variables and 28 day-mortal-
ity. Only hemodynamic variables showing no collinearity with
each other (correlation coefficient <0.65) were entered into
the regression models. As cardiac index and cardiac power
index were strongly correlated (Pearson correlation coeffi-
cient, 0.913; P < 0.001) two separate multivariate logistic
regression models were calculated once including cardiac
index and once including cardiac power index. All models
were adjusted for age, admission year, mean catecholamine
(epinephrine, norepinephirne, dobutamine and milrinone) dos-
ages and SAPS II (excluding systolic arterial blood pressure
and heart rate) which were entered as linear covariates into the
models in order to account for the influence of age, changes
in therapies during the observation period, the severity of car-
diovascular failure and the severity of the underlying disease
on 28-day mortality.
To address the secondary endpoint, the area under the
receiver operator characteristic (ROC) curve for the hourly var-
iable time integral of drops below clinically relevant threshold
levels of those hemodynamic variables significantly associated
with 28-day mortality were determined. Additionally,
sensitivity, specificity, as well as negative and positive predic-
tive values of these variables to predict 28-day mortality was
calculated from the final classification tables of the adjusted
logistic regression models. The threshold level with the high-
est area under the ROC curve was considered to best predict
28-day mortality. Furthermore, the relative risk of death at day
28 of each threshold level was evaluated to further differenti-
ate between the predictive value of each threshold level. To
assess the association between hemodynamic variables and
arterial lactate as well as base deficit, linear regression models
were used. Again, these models were adjusted for age, admis-
sion year, catecholamine dosages and SAPS II (excluding
systolic arterial blood pressure and heart rate). P-values less
than 0.05 were considered to indicate statistical significance
in all models. Data are given as mean values ± standard devi-
ation, if not otherwise indicated.
Results
During the observation period, 11,172 patients were admitted
to the intensive care unit. Five patients were excluded because
they received a mechanical assist device before or during the
first 24 hours after intensive care unit admission. One hundred
and nineteen patients fulfilled the inclusion criteria and were
included into the analysis (Table 1). Heart rate, arterial blood
pressure, central venous blood pressure/mean perfusion pres-
sure as well as pulmonary artery catheter-related variables
were recorded for 22.2 ± 2.9 hours, 21.7 ± 3.5 hours, 19.3 ±
5.3 hours and 19 ± 5 hours, respectively (Figure 2). Four
patients died during the 24 hours of observation. Intensive
care unit and 28-day mortality of the study population was
19.3% (23/119) and 29.4% (35/119). Seventy-four percent
(n = 56) of patients with cardiogenic shock because of an
acute coronary syndrome underwent a percutaneous coronary
intervention. Stents were placed in 80.4% (n = 45) of these
patients. The type and frequency of reperfusion therapies initi-
ated before intensive care unit admission in patients with
acute coronary syndrome as the cause of cardiogenic shock
did not change during the observation period (2005, 72.7%;
2006, 70%; 2007, 73.9%; 2008, 90%; P = 0.66, chi-squared
test). Cardiopulmonary resuscitation was performed in 18.5%
(n = 22) of study patients before intensive care unit admission.
Therapeutic hypothermia was not applied in these patients
because of cardiogenic shock.
Non-survivors at day 28 were older, had lower mean cardiac
and cardiac power indices, higher epinephrine requirements,
higher arterial lactate levels, SAPS II and SOFA score counts,
required renal replacement therapy more often and had a
shorter intensive care unit stay than survivors (Table 2). In the
multivariate regression models, the hourly cardiac index and
cardiac power index time integrals were the only hemody-
namic variables during the first 24 hours after intensive care
unit admission significantly associated with 28-day mortality
(Tables 3 and 4). The hourly time integral of cardiac index and
cardiac power index drops below 3 L/min/m2 and 0.8 W/m2,
respectively, revealed the highest area under the ROC curve
(Table 5). The relative risk of death was positive when cardiac
index and cardiac power index dropped below 3 L/min/m2 and
0.8 W/m2, respectively. With drops below lower threshold lev-
els, the relative risk of death at day 28 remained more or less
unchanged until a cardiac index and cardiac power index of 2
L/min/m2  and 0.4 W/m2, respectively, when a substantial
increase in the relative risk of death occurred (Table 5).Available online http://ccforum.com/content/13/5/R157
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Of all hemodynamic variables during the first 24 hours after
intensive care unit admission, only the hourly cardiac index
time integral was associated with base deficit (standardized
Beta coefficient, 0.176; P = 0.04). No hemodynamic variable
was associated with arterial lactate levels but epinephrine
(standardized Beta coefficient, 0.341; P = 0.002) and nore-
pinephrine doses were associated (standardized Beta coeffi-
cient, 0.517; P < 0.001).
Discussion
In this retrospective analysis, cardiac index and cardiac power
index were separately associated with 28-day mortality in 119
cardiogenic shock patients. A cardiac index of 3 L/min/m2 and
a cardiac power index of 0.8 W/m2 during the first 24 hours
after intensive care unit admission were best predictive of 28-
day mortality. Cardiac index was associated with base deficit.
Despite the fact that almost two-thirds of the study population
developed cardiogenic shock as a result of an acute coronary
syndrome, 28-day mortality was comparatively low [18-22].
This could be attributable to early and aggressive interven-
tional measures to re-vascularize ischemic myocardium.
As therapeutic interventions during the early phase of cardio-
genic shock are crucial for survival [18,19], we chose to inves-
tigate the association between hemodynamic variables during
the first 24 hours after intensive care unit admission and out-
come. However, it must be considered that the first 24 hours
of intensive care unit therapy usually do not represent the first
Figure 2
Histograms showing the time in hours of hemodynamic variable recordings in the study population Histograms showing the time in hours of hemodynamic variable recordings in the study population.  CVP = central venous pressure; HR = heart 
rate; MAP = mean arterial blood pressure; PAC = pulmonary artery catheter.Critical Care    Vol 13 No 5    Torgersen et al.
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24 hours of the disease process. This led to a certain lead-time
bias in our analysis which is difficult to quantify and may have
influenced the association between hemodynamic variables
and mortality. Similarly, our analysis does not take the influ-
ence of hemodynamic changes occurring more than 24 hours
after intensive care unit admission on mortality into account.
On the other hand, a major strength of our analysis is that it
assessed variable time integrals instead of single or averaged
absolute values of different hemodynamic parameters as so far
evaluated in previous clinical studies [20-22]. This variable
integrates the influence of two important dimensions, namely
the duration and extent of hemodynamic changes, on indices
of tissue perfusion and mortality.
Of all the hemodynamic variables, cardiac index and cardiac
power index were significantly associated with 28-day mortal-
ity in our cardiogenic shock population. As reflected by the
association between cardiac index and base deficit, it appears
that this association is at least partly related to tissue per-
fusion. These observations are in accordance with previous
studies [20-22] and the current pathophysiologic understand-
ing of cardiogenic shock [11]. Similar to our results, Fincke
and colleagues analysed 541 cardiogenic shock patients of
the SHOCK trial registry and observed that cardiac power
was the strongest independent correlate of in-hospital mortal-
ity [20]. Another post hoc analysis of a large acute myocardial
infarction database reported that cardiac output, pulmonary
artery occlusion pressure and mean arterial blood pressure
were associated with 30-day mortality in cardiogenic shock
[21]. Other authors found similar results [22]. In contrast to
these studies, which analysed hemodynamic variables meas-
ured at arbitrarily selected time points, our analysis evaluated
continuous measurements during the first 24 hours after inten-
sive care unit admission and thereby allowed the investigation
of the association between the evolution of hemodynamic var-
iables over time and outcome in cardiogenic shock.
Furthermore, statistical models applied in this analysis were all
adjusted for age, admission year, catecholamine dosages and
SAPS II to account for the influence of age, changes in thera-
pies during the observation period, the severity of cardiovas-
cular failure and the severity of the underlying disease on 28-
day mortality. Therefore, our results may better reflect the true
impact of hemodynamic variables on indices of tissue per-
fusion and mortality than earlier studies [18-20]. Nonetheless
we cannot exclude that other variables not included in the
regression models influenced the association between hemo-
dynamic variables and mortality. Additionally, it must be con-
sidered that although our models were adjusted for
catecholamine requirements, cardiac index or cardiac power
index may not be fully comparable between study patients
receiving low- or high-dosed catecholamine infusions.
Although the association between cardiac index, cardiac
power index and mortality in cardiogenic shock may be
expected, none of the hemodynamic variables commonly
measured was associated with outcome in our analysis. It is
conceivable that some variables (e.g. mean arterial blood pres-
sure, central venous blood pressure or systemic vascular
resistance index) may have been significant had more patients
Table 1
Characteristics of the study population (n = 119)
Age (years) 67 ± 14
Male sex (%) 71 (59.7)
Premorbidities (%)
Chronic arterial hypertension 41 (34.5)
Coronary heart disease 60 (50.4)
Congestive heart failure 37 (31.1)
Chronic atrial fibrillation 13 (10.9)
Chronic obstructive pulmonary disease 16 (13.4)
Chronic renal insufficiency 33 (27.7)
Chronic liver disease 22 (18.5)
Neoplasm 5 (4.2)
Obesity/metabolic syndrome 27 (22.7)
Cause of shock (%)
Acute coronary syndrome 76 (63.9)
Decompensation of chronic cardiomyopathy 30 (25.2)
Cardiomyopathy of unknown etiology 6 (5)
Acute viral myocarditis 3 (2.5)
Acute arrhythmia 1 (0.8)
Mechanical complication 3 (2.5)
Source of admission (%)
Emergency department 37 (31.1)
Other hospital 46 (38.7)
Other intensive care unit 23 (19.7)
Hospital ward 13 (10.9)
Sequential organ failure assessment 10.8 ± 3.1
Simplified acute physiology score II 52 ± 17
Need for mechanical ventilation (%) 98 (82.4)
Invasive mechanical ventilation 92 (77.3)
Non-invasive mechanical ventilation 6 (5)
Need for renal replacement therapy (%) 22 (18.5)
Intra-aortic balloon pump (%) 45 (37.8)
Need for ventricular assist device* (%) 14 (11.8)
Intensive care unit length of stay (days) 7.2 ± 8.7
*Ventricular assist devices include Heart Mate®, Tandem Heart®, 
Thoratec® or Impella® devices. Initiated more than 24 hours after 
intensive care unit admission. Data are given as mean values ± 
standard deviation, if not otherwise indicated.Available online http://ccforum.com/content/13/5/R157
Page 7 of 11
(page number not for citation purposes)
been included. Moreover, these variables were used as end-
points of resuscitation and could underlie a certain treatment
bias. Given the pathophysiology of cardiogenic shock, cardiac
index and cardiac power index could partly reflect the failure of
hemodynamic interventions to influence these hemodynamic
endpoints. Although only statistically non-collinear hemody-
namic variables were entered into the multivariate regression
model, it is also likely that a clinical correlation exists between
most hemodynamic variables. Therefore, collinearity may be an
inherent problem of multivariate analyses including different
hemodynamic variables. However, supporting the main results
of our analysis, cardiac index and cardiac power index were
significant and showed the strongest association with 28-day
mortality in both regression models.
Table 2
Demographics and clinical data of survivors and nonsurvivors at 28 days
Survivors
n = 84
Nonsurvivors
n = 35
P value
Age (years) 65 ± 14 71 ± 12 0.01*
Male sex (%) 54 (64.3) 17 (48.6) 0.15
Heart rate (bpm) 94 ± 14 97 ± 16 0.36
SAP (mmHg) 92 ± 12 91 ± 15 0.69
MAP (mmHg) 66 ± 7 64 ± 7 0.19
DAP (mmHg) 51 ± 7 49 ± 7 0.07
MPP (mmHg) 53 ± 8 51 ± 9 0.26
CVP (mmHg) 12 ± 3 13 ± 3 0.12
MPAP† (mmHg) 28 ± 6 28 ± 6 0.89
PAOP† (mmHg) 18 ± 5 18 ± 4 0.64
CPP† (mmHg) 31 ± 7 30 ± 9 0.3
CI† (l/min/m2) 2.7 ± 0.5 2.4 ± 0.4 0.003*
CPI† (W/m2) 0.39 ± 0.08 0.34 ± 0.38 0.005*
SvO2† (%) 64 ± 6 62 ± 9 0.14
SVRI (dyne*s/cm5/m2) 1760 ± 664 1779 ± 357 0.89
Epinephrine# n = 50 (μg/h) 61 ± 130 195 ± 317 0.03*
Norepinephrine# n = 37 (μg/h) 26 ± 85 17 ± 54 0.6
Dobutamine# n = 89 (mg/h) 8 ± 7 10 ± 8 0.11
Milrinone# n = 14 (mg/h) 0.07 ± 0.24 0.07 ± 0.25 0.99
Nitroprusside# (mg/h) 1.87 ± 3.68 1.49 ± 2.75 0.6
Arterial lactate§ (mmol/l) 4.1 ± 3.3 6.4 ± 4 0.002*
Troponin T§ (μg/l) 54 ± 103 114 ± 228 0.19
RRT (%) 10 (11.9) 12 (34.3) 0.008*
SOFA score§ 10 ± 3 12 ± 3 0.007*
SAPS II 49 ± 15 61 ± 17 < 0.001*
ICU LOS (days) 8.1 ± 9.8 5 ± 4.6 0.02*
Hemodynamic parameters reflect mean values during the first 24 hours after ICU admission.
* significant difference between survivors and nonsurvivors; † 92 (77.2%) patients were monitored with a pulmonary arterial catheter; # mean 
hourly dosage during the first 24 hours after ICU admission; § maximum values during the ICU stay.
Data are given as mean values ± standard deviation, if not otherwise indicated.
CI = cardiac index; CPI = cardiac power index; CPP = coronary perfusion pressure; CVP = central venous blood pressure; DAP = diastolic 
arterial blood pressure; ICU = intensive care unit; LOS = length of stay; MAP = mean arterial blood pressure; MPAP = mean pulmonary arterial 
blood pressure; MPP = mean perfusion pressure; PAOP = pulmonary arterial occlusion pressure; RRT = need for renal replacement therapy; SAP 
= systolic arterial blood pressure; SOFA = sequential organ failure assessment; SvO2 = mixed venous oxygen saturation; SVRI = systemic 
vascular resistance index.Critical Care    Vol 13 No 5    Torgersen et al.
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According to the Wald statistics of the regression models, a
certain priority rank order for the early resuscitation of cardio-
genic shock patients could be established. Based on this, it
appears that early hemodynamic resuscitation should focus on
increasing systemic blood flow during cardiogenic shock. Fur-
thermore, it may be hypothesized that rising systemic vascular
resistance simply to maintain arterial blood pressure may not
be beneficial. Accordingly, only an early increase of systemic
blood flow was associated with survival in this study
population.
Considering the double-edged effects of catecholamines on
the heart and tissue perfusion [1,4-11], it is a central clinical
q u e s t i o n  o f  t o  w h a t  l e v e l s  systemic blood flow should be
increased to improve mortality. As suggested by the compari-
son between survivors and non-survivors in our analysis as
well as by results of previous studies [23], infusion of epine-
phrine may be particularly harmful. In view of the fact that this
study was retrospective and explorative, our results must be
considered as hypothesis generating. Accordingly, the
adjusted models suggest that a cardiac index of 3 L/min/m2
and a cardiac power index of 0.8 W/m2 were best predictive
of 28-day mortality in our study population. Considering that
the relative risk of death at day 28 turned positive when car-
diac index and cardiac power index dropped below 3 L/min/
m2 and 0.8 W/m2, respectively, and substantially increased
with cardiac index drops below 2 L/min/m2 and cardiac power
index drops below 0.4 W/m2, it is likely that a clinically relevant
threshold level for 28-day mortality exists between a cardiac
index of 2-3 L/min/m2 and a cardiac power index between 0.8
and 0.4 W/m2. However, considering the reduced number of
patients experiencing cardiac index and cardiac power index
drops below very low threshold levels, these results must be
interpreted with caution and need to be confirmed in a larger
patient population. Comparable cut-off values for cardiac out-
put (5.1 L/min ~ about 2.9 L/min/m2 in an adult with 1.73 m2
body surface area) and cardiac power output (1 W ~ about
0.58 W/m2 in an adult with 1.73 m2 BSA) were reported
[21,22]. However, these models were neither adjusted for
confounding factors nor disease severity. Furthermore, it is
important to note that the threshold levels suggested in our
study did not represent treatment goals but were retrospec-
tively defined. Their use as resuscitation goals in early cardio-
genic shock must be evaluated in future randomized controlled
trials. In such a trial, the safety of targeting these endpoints
must also be evaluated. This is particularly relevant in face of
the lacking positive or even negative results of previous large
studies on the outcome effects of targeting supra-normal oxy-
gen delivery in critically ill patients [24,25].
When interpreting our study results important limitations need
to be considered. First, our analysis was retrospective and
shortcomings such as missing values cannot be excluded
despite all hemodynamic variables being prospectively
recorded. Second, although inclusion criteria were present in
all study patients, we cannot exclude that more of the 11,172
patients admitted to our intensive care unit during the obser-
vation period may have been considered as having cardio-
genic shock by other definitions. Together with the fact that
five patients who received a mechanical assist device before
Table 3
Separate adjusted logistic regression models to detect associations between single hemodynamic variables and 28-day mortality
Wald RR 95% Con Int P value
CI time integral† (l/m2/h) 6.097 0.972 0.951-0.994 0.01*
CPI time integral† (W/m2 *min/h) 4.491 0.864 0.755-0.989 0.03*
SvO2 time integral† (%*min/h) 2.315 0.999 0.998-1 0.13
SVRI time integral† (dyne*s/cm5/m2 *min/h) 1.776 1 1-1 0.18
MPP time integral (mmHg*min/h) 0.999 1.001 0.999-1.002 0.32
HR time integral (bmp*min/h) 0.972 1 1-1.001 0.32
MAP time integral (mmHg*min/h) 0.178 1 0.999-1.002 0.67
MPAP time integral† (mmHg*min/h) 0.158 1 0.998-1.001 0.69
SAPS time integral (mmHg*min/h) 0.107 1 1-1.001 0.46
CVP time integral (mmHg*min/h) 0.013 1 0.997-1.003 0.91
DAP time integral (mmHg*min/h) 0 1 0.999-1.001 1
Single logistic regression models were calculated for each hemodynamic variable and were each adjusted for age, admission year, mean 
catecholamine (epinephrine, norepinephrine, dobutamine and milrinone) dosages and SAPS II (excl. the systolic arterial blood pressure and heart 
rate count). Variables are ranked (top to bottom) according to the value of the Wald statistics. * significant association with 28 day-mortality; † 92 
(77.2%) patients were monitored with a pulmonary arterial catheter.
CI = cardiac index; Con Int = confidence interval; CPI = cardiac power index; CVP = central venous blood pressure; HP = hourly portion; MAP = 
mean arterial blood pressure; MPAP = mean pulmonary arterial blood pressure; RR = relative risk; SAPS II = Simplified Acute Physiology Score II 
(excl. heart rate and systolic arterial blood pressure counts); SvO2 = mixed venous oxygen saturation; SVRI = systemic vascular resistance index.Available online http://ccforum.com/content/13/5/R157
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or during the first 24 hours after intensive care unit admission
were excluded, this may represent a selection bias of our anal-
ysis. Third, although artefacts in monitored trends of hemody-
namic variables were eliminated, we cannot rule out that
malposition of the reference level of invasively measured blood
pressures or a low signal quality index of mixed venous oxygen
saturation measurements was present in some patients for a
limited time. As close monitoring of the correct reference posi-
tion and signal quality index is a standard operational proce-
dure at our intensive care unit, we do not believe that this
potential limitation is the reason why no significant association
between certain hemodynamic variables and mortality could
be identified. Fourth, measurement of base deficit and arterial
lactate levels may have been insufficient to reliably evaluate
global tissue perfusion. Particularly arterial lactate levels are
influenced by other factors than tissue hypoxia alone [26]. As
confirmed by our results, catecholamines are well known to
increase arterial lactate levels either by exaggerated simulation
of aerobic glycolysis and lactate production [27] or induction
of tissue hypoperfusion by inappropriate vasoconstriction
[28,29].
Conclusions
During the first 24 hours after intensive care unit admission,
cardiac index and cardiac power index are the most important
hemodynamic variables separately associated with 28-day
mortality in patients with cardiogenic shock. A cardiac index of
3 L/min/m2 and a cardiac power index of 0.8 W/m2 were best
predictive of 28-day mortality. As our results must be consid-
ered hypothesis generating, randomized controlled trials are
required to evaluate whether targeting these levels as early
resuscitation endpoints can improve mortality in cardiogenic
shock.
Table 4
Adjusted multivariate logistic regression models to detect independent associations between hemodynamic variables and 28-day 
mortality
Wald RR 95% Con Int P value
Model I - including cardiac index
CI time integral† (l/m2/h) 6.658 0.914 0.854-0.979 0.01*
CVP time integral (mmHg*min/h) 4.010 0.995 0.99-1 0.06
SVRI time integral† (dyne*s/cm5/m2 *min/h) 3.832 1 1-1 0.06
MAP time integral (mmHg*min/h) 2.914 1.003 1-1.006 0.09
HR time integral (bpm*min/h) 1.833 1.001 1-1.001 0.18
SvO2 time integral† (%*min/h) 0.069 1 0.998-1.002 0.79
MPAP time integral† (mmHg*min/h) 0.001 1 0.998-1.002 0.97
Model II - including cardiac power index
CPI time integral† (W/m2 *min/h) 6.281 0.648 0.462-0.91 0.01*
MAP time integral (mmHg*min/h) 4.109 1.003 1-1.007 0.06
CVP time integral (mmHg*min/h) 3.076 0.996 0.991-1 0.08
SVRI time integral† (dyne*s/cm5/m2 *min/h) 2.739 1 1-1 0.1
HR time integral (bpm*min/h) 2.072 1.001 1-1.001 0.15
MPAP time integral† (mmHg*min/h) 0.086 1 0.998-1.002 0.77
SVO2 time integral† (%*min/h) 0.002 1 0.998-1.002 0.97
All models were adjusted for age, admission year, mean catecholamine (epinephrine, norepinephrine, dobutamine, and milrinone) dosages and 
SAPS II (excl. the systolic arterial blood pressure and heart rate count). Variables are ranked (top to bottom) according to the value of the Wald 
statistics. * significant association with 28 day-mortality; † 92 (77.2%) patients were monitored with a pulmonary arterial catheter.
CI = cardiac index; Con Int = confidence interval; CPI = cardiac power index; CVP = central venous blood pressure; HP = hourly portion; HR = 
heart rate; MAP = mean arterial blood pressure; MPAP = mean pulmonary arterial blood pressure; RR = relative risk; SvO2 = mixed venous 
oxygen saturation; SVRI = systemic vascular resistance index.Critical Care    Vol 13 No 5    Torgersen et al.
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Key messages
￿  Despite the key role of hemodynamic goals, there are 
few data addressing the question of whether hemody-
namic variables are associated with patient mortality or 
should be used as treatment goals in cardiogenic 
shock.
￿  During the first 24 hours after intensive care unit admis-
sion, cardiac index and cardiac power index are the 
most important hemodynamic variables separately asso-
ciated with 28-day mortality in cardiogenic shock 
patients.
￿  A cardiac index of 3 L/min/m2 and a cardiac power 
index of 0.8 W/m2 were best predictive of 28-day 
mortality.
￿  Randomized controlled trials are required to evaluate 
whether targeting these levels as early resuscitation 
endpoints can improve mortality in cardiogenic shock.
Table 5
Association between different cardiac index/cardiac power index levels and 28-day mortality
n (%) AUC ROC Sens (%) Spec (%) PPV (%) NPV (%) RR 95% Con Int
HP between different CI levels
HTI of CI drops <3.75 l/min/m2 92 (100) 0.80 42.9 90.5 66.7 78.1 0.98 0.96-1.00
HTI of CI drops <3.50 l/min/m2 92 (100) 0.80 42.9 90.5 66.7 78.1 0.98 0.96-1.00
HTI of CI drops <3.25 l/min/m2 92 (100) 0.80 42.9 90.5 66.7 78.1 0.98 0.96-1.00
HTI of CI drops <3.00 l/min/m2 92 (100) 0.81 46.4 92.1 72.2 79.5 1.04 1.01-1.07
HTI of CI drops <2.75 l/min/m2_ 87 (94.6) 0.80 46.4 92.1 72.2 79.5 1.04 1.01-1.08
HTI of CI drops <2.50 l/min/m2 84 (91.3) 0.79 39.3 92.1 68.6 77.3 1.05 1.00-1.10
HTI of CI drops <2.25 l/min/m2 73 (79.3) 0.78 39.3 92.1 68.8 77.3 1.06 0.99-1.14
HTI of CI drops <2.00 l/min/m2 58 (63) 0.77 35.7 90.5 62.5 76.0 1.11 0.96-1.27
HTI of CI drops <1.75 l/min/m2 38 (41.3) 0.77 39.3 93.7 73.3 77.6 1.34 0.95-1.89
HTI of CI drops <1.50 l/min/m2 22 (23.9) 0.76 32.1 92.1 64.3 75.3 1.46 0.69-3.10
HP below different CPI levels
HTI of CPI drops <1.2 W/m2 92 (100) 0.81 39.3 88.9 61.1 76.7 0.86 0.75-0.98
HTI of CPI drops <1.1 W/m2 92 (100) 0.81 39.3 88.9 61.1 76.7 0.86 0.75-0.98
HTI of CPI drops <1.0 W/m2 92 (100) 0.81 39.3 88.9 61.1 76.7 0.86 0.75-0.98
HTI of CPI drops <0.9 W/m2 92 (100) 0.81 39.3 88.9 61.1 76.7 0.86 0.75-0.98
HTI of CPI drops <0.8 W/m2 92 (100) 0.81 39.3 88.9 61.1 76.7 1.16 1.01-1.33
HTI of CPI drops <0.7 W/m2 92 (100) 0.80 39.3 88.9 61.1 76.7 1.16 1.01-1.33
HTI of CPI drops <0.6 W/m2 91 (98.9) 0.80 39.3 88.9 61.1 76.7 1.16 1.01-1.33
HTI of CPI drops <0.5 W/m2 91 (98.9) 0.79 39.3 90.5 64.7 77.0 1.17 1.00-1.35
HTI of CPI drops <0.4 W/m2 91 (98.9) 0.79 39.3 90.5 64.7 77.0 1.20 0.98-1.47
HTI of CPI drops <0.3 W/m2 69 (75) 0.78 35.7 92.1 66.7 76.3 1.46 0.86-2.47
Single Receiver Operating Characteristic Curve Models were based on logistic regression models adjusted for age, admission year, mean 
catecholamine (epinephrine, norepinephrine, dobutamine, and milrinone) dosages and disease severity as assessed by the Simplified Acute 
Physiology Score II (excl. heart rate and systolic arterial blood pressure counts).
AUC ROC = area under the receiver operating characteristic curve; CI = cardiac index; Con Int = confidence interval; CPI = cardiac power index; 
HTI = hourly time integral; NPV = negative predictive value; PPV = positive predictive value; RR = relative risk; Sens = sensitivity; Spec = 
specificity.Available online http://ccforum.com/content/13/5/R157
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